6/28 - Diseases of Immune System Flashcards

(80 cards)

1
Q

immune reactant for Type II HS

A

IgG and some cases IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

antigen for Type II HS

A

cellular or extracellular matrix antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what causes type II HS? what does it result in?

A

cause: destruction of cells
result: inflammation or interference w/ normal cell function (dysfunction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mechanisms of type II HS

A
  1. opsonization and phagocytosis (destruction)
  2. inflammation (destruction)
  3. cellular dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe opsonization and phagocytosis in type II HS

A

antibody coats cell and and is marked for phagocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what causes tissue damage in type II HS

A

cellular lysis induced by direct binding of antibody to cell surface antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what do antibodies attack in inflammation of type II HS

A

attack leukocytes or RBCs (mobile cells) or bind to fixed cells (part of solid tissues)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do antibodies involved in inflammation activate? what does this result in

A

activate complement generating by-products , including chemotactic agents (mainly C5a)

this directs migration of neutrophils and monocytes and anaphylaxtonins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the anaphylatoxins? what does it do?

A

C3a, C4a, and C5a
increase vascular permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pathway for type II HS inflammation and tissue injury

A
  1. antigen + target cell + antibody
    • complement protein (C3a and mainly C5a)
      3a. complement 5b-9MAC
      3b. + membrane attack complex (MAC) insert into cell
      4b. results in osmotic lysis or drill holes in cell membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2 main examples of antibody-mediated cellular destruction. what type of HS?

A
  1. autoimmune hemolytic anemia
  2. erythroblastosis fetalis (hemolytic disease of newborn)

both type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the disease where individuals produce antibodies to their own blood? HS type?

A

autoimmune hemolytic anemia - type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the disease where there is an antigenic difference between mother and fetus and IgG antierythrocyte antibodies from the mother cross the placenta and destroy the fetal red cells? HS type?

A

erythroblastosis fetalis - type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the two main examples of cellular dysfunction for type II HS

A
  1. myasthenia gravis (interferes w/ cellular function)
  2. grave’s disease (cellular hyperfunction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what disease:

antibodies reactive with Ach receptors in motor end plates of skeletal muscles block neuromuscular transmission and cause muscle weakness? what type of HS

A

myasthenia gravis - type II HS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what disease:

antibody-mediated stimulation of cell function is the basis; antibodies against the TSH receptors on thyroid epithelial ells stimulate the cells, resulting in hyperthyroidism

what type of HS

A

Grave’s disease = type II HS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

autoimmune hemolytic anemia

target antigen, mechanism of disease, clinical manifestation, HS type

A

TA: red cell membrane protein
MoD: opsonization and phagocytosis of RBCs
CM: hemolysis anemia
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

autoimmune thrombolytic purpura

target antigen, mechanism of disease, clinical manifestation, HS type

A

TA: platelet membrane protein
MoD: opsonization and phagocytosis of platelets
CM: bleeding
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

B)

pemphigus vulgaris

target antigen, mechanism of disease, clinical manifestation, HS type

A

TA: protein in intercellular junctions
MoD: antibody-mediated activation of proteases disruption of intercellular adhesion
CM: skin vesicles
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

vasculitis caused by antineutrophil cytoplasmic AB

target antigen, mechanism of disease, clinical manifestation

A

TA: neutrophil granule proteins released from activated neutrophils
MoD: neutrophil degranulation and inflammation
CM: vasculitis
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

good pasture syndrome

target antigen, mechanism of disease, clinical manifestation, HS type

A

TA: non collagenous protein in BM of kidneys
MoD: complement and Fc receptor mediated inflammation
CM: nephritis, lung hemorrhage
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

acute rheumatic fever

target antigen, mechanism of disease, clinical manifestation, HS

A

TA: streptococcal cell wall antigen, antibody-cross react w/ myocardial antigens
MoD: inflammation, macrophage activation
CM: myocarditis, arthritis
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

myasthenia gravis

target antigen, mechanism of disease, clinical manifestation, HS type

A

TA: Ach receptors
MoD: antibody inhibits acetylcholine binding, down modulates receptors
CM: muscle weakness, paralysis
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

insulin-resistant diabetes

target antigen, mechanism of disease, clinical manifestation, HS type

A

TA: insulin receptor
MoD: antibody inhibits binding to insulin
CM: hyperglycemia, ketoacidosis
HS: type II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
graves disease target antigen, mechanism of disease, clinical manifestation, HS type
TA: TSH receptors MoD: antibody mediated stimulation of TSH receptors CM: hyperthyroidism HS: type II
26
pernicious anemia target antigen, mechanism of disease, clinical manifestation, HS type
TA: intrinsic factor of gastric parietal cells MoD: neutralizatin of intrinsic factor, decreased absorption of Vit B CM: abnormal erythropoiesis anemia HS: type II
27
immune reactant for type III HS
IgG or IgM
28
antigen for type III HS
solubule antigen
29
type III HS rxn is mediated by formation of what
antigen-antibody aggregates called immune complexes
30
how are type III HS rxns frequently initiated
when antigens combine with antibodies in circulation (creating immune complexes)
31
how are type III HS rxns less frequently initiated
when immune complexes are formed at sites where antigen has been "planted" previously
32
type III HS immune complexes can precipitate in various tissues (such as skin, joints, vessels, or glomeruli) resulting in what?
tissue damage and inflammation at the site of deposition thru triggering of classical complement pathway
33
in type III HS rxn, antigens may form immune complexes that are [exogenous OR endogenous]
BOTH! exogenous AND endogenous
34
what is a foreign protein that is injected or produced by an infectious microbe
exogenous rxns
35
what are self antigens/autoimmuniy?
endogenous rxns
36
what is an acute, localized inflammatory response that typically occurs after vaccination? type of HS
acute Arthus rxns - type III
37
what mediates acute Arthus rxns?
antigen is injected or enters intradermally or subcutaneously, they bind w/ antibody to form localized immune complexes
38
when do acute arthus rxn form
within 4-8 hours
39
as acute arthus rxn develops, localized tissue damage and vascular damage results in what?
accumulation of fluids (edema) and RBCs (erythema) at site of antigen entry
40
what disease: large amounts of antigen enter blood stream (vaccinations of multiple insect bites) and bind to antibody, circulating immune complex forms? type of HS
serum sickness - type III
41
what disease involve immune complexes that are smaller and soluble and not phagocytosed by phagocytic cells leading to abnormal immune rxn? type of HS
serum sickness - type III
42
manifestation of serum sickness depends on what
1. quantity of immune complex 2. overall site of deposition 3. accumulation of complexes occurring at site of blood filtration
43
generalized type III HS rxn at different site results in what?
different diseases: 1. glomerulonephritis - kidney 2. vasculitis - arteries 3. arthritis - synovial joints
44
systemic lupus erythematosus antigen involved, clinical manifestation, and HS type
AI: nuclear antigen (circulated or planted in kidney) CM: nephritis, skin lesions, arthritis others HS: III
45
poststreptococcal glomerulonephritis antigen involved, clinical manifestation, and HS type
AI: streptococcal cell wall antigens; may be planted in glomerular basement membrane CM: nephritis HS: III
46
polyarteritis nodosa antigen involved, clinical manifestation, and HS type
AI: hep B virus antigen in some cases CM: systemic vasculitis HS: III
47
reactive arthritis antigen involved, clinical manifestation, and HS type
AI: bacterial antigens CM: acute arthritis HS: III
48
serum sickness antigen involved, clinical manifestation, and HS type
AI: various proteins (e.g. foreign serum protein) CM: arthritis, vasculitis, nephritis HS: III
49
arthus rxn antigen involved, clinical manifestation, and HS type
AI: various foreign proteins CM: cutaneous vasculitis HS: III
50
! what HS is cell-mediated delayed rxn
type IV
51
type IV HS invovles interaction of what cells
T cells, monocytes, and macrophages
52
type IV rxn is also called what
delayed-type HS
53
how long does it take for type IV to develop
several days
54
what rnx is mediated by T cells that provoke inflmamatory rxn against exogenous or endogenous antigens
type IV
55
what HS rxn can occur in response to contact w/ certain allergens (contact dermatitis) or in response to some diagnostic procedures as in the tuberculin skin test
type IV HS
56
pathway of type IV HS rxn
1. activated CD4+ T h1 cells recognized foreign antigen in complex w/ MHC class II on surface of antigen presenting cells 2. secrete: IL2 & interferon gamma thus mediatin immune response
57
do activated CD8+ T cells destroy target cells on contact
YES
58
activated macrophages produce hydrolytic enzymes and on presentation w/ certain intracellular pathogens, transform into what?
multinucleated giant cells
59
what is also known as purified protein derivative
tuberculin
60
what is a combination of proteins that are used in the diagnosis of TB
tuberculin
61
when is TB test considered positive
after 48-72 hours, if there is more than 5-10 mm area of swelling
62
microscopically, what is causing TB test to be positive
CD4+, TH1 cells secrete cytokines (most importantly INF-gamma) causing vascular leakage leading to edema and fibrin deposition
63
with persistent or nondegradable antigens colonizing the lungs or other tissues, the infiltration in TB is dominated by ___ over a period of 2-3 weeks
macrophages
64
dominated macrophages in TB undergo transformation into ___
epithelioid cells
65
what is a microscopic aggregation of epithelioid cells, usually surrounded by a collar of lymphocytes
granuloma/granulomatous inflammation
66
B! what are the clinical conditions which granulomas are formed
1. myobacteria tuberculosis 2. deep fungal infections 3. parasitic infections 4. foreign bodies
67
what results from the contact of an offending chemical or antigen w/ the skin, and the subsequent T-cell mediated response
allergic contact dermatitis
68
what is an inflammatory disease of the skin
allergic contact dermatitis
69
what are the best indicators of the offending agent in ACD
morphology and location of the dermatitis
70
what is a common cause of ACD and presents as linear streaks where the plant encounters the skin
poison ivy
71
what is a common cause of ACD and presents as dermatitis where necklaces and earrings containing this are worn
nickel
72
what is a common cause of CHRONIC dermatitis
rubber glvoes
73
what cells mediate ACD
CD8+ T cells
74
where are ACD CD8+ T cells primed? recruited?
primed: lymphoid organs during sensitization phase recruited: into the skin upon exposure to antigen
75
rheumatoid arthritis specificity of pathogenic T cells, mechanism of tissue injury, clinical manifestation, and HS type
specificity: collagen, citrullinated self-protein MoT: inflammation mediated by cytokines, role of antibodies and immune complexes? CM: chronic arthritis w/ inflammation, destruction of articular cartilage HS: III
76
multiple sclerosis specificity of pathogenic T cells, mechanism of tissue injury, clinical manifestation, and HS type
specificity: protein antigen in myelin sheath MoT: inflammation mediated by cytokines, myeline destruction by activated macrophages CM: demylenination in CNS w/ perivascular inflammation; paralysis HS: IV
77
type I DM specificity of pathogenic T cells, mechanism of tissue injury, clinical manifestation, and HS type
specificity: antigen of pancreatic islet of beta cell MoT: t cell mediated inflammation; destruction of islet cells by CTLs (CD8 T lymphocytes??) CM: chronic inflammation of islets, destruction of beta cells, diabetes HS: IV
78
inflammatory bowel disease specificity of pathogenic T cells, mechanism of tissue injury, clinical manifestation, and HS type
specificity: enteric bacteria, self antigens? MoT: inflammation by cytokines CM: chronic intesetinal inflammation HS: IV
79
psoriasis specificity of pathogenic T cells, mechanism of tissue injury, clinical manifestation, and HS type
specificity: unkown MoT: inflammation mediated by cytokines CM: destructive plaques in the skin HS: IV
80
contact dermatitis specificity of pathogenic T cells, mechanism of tissue injury, clinical manifestation, and HS type
specificity: various environmental chemicals (uroshiol from poison ivy or poison oak) MoT: inflammation mediated by cytokines CM: epidermal necrosis, dermal inflammation, causing skin rash and blisters HS: IV